Journalism of Courage
CORONAVIRUS NEWS - Page 9
AstraZeneca manufacturing error clouds vaccine study results
November 26, 2020 09:01 IST
In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses.
UP’s COVID management has been acknowledged globally: Yogi Adityanath
November 23, 2020 14:52 IST
Stressing that the BSL laboratories will not only help in dealing with the coronavirus, but also other similar diseases, Adityanath said it would reduce the state's dependence on the Pune institute.
AstraZeneca COVID-19 vaccine can be 90% effective, results show
November 24, 2020 09:32 IST
Another dosing regimen showed 62% efficacy when given as two full doses at least one month apart and the combined analysis from both dosing regimens resulted in an average efficacy of 70%. All results were statistically significant.
Scientist Hitoshi Oshitani who saved Japan once battles a new virus surgeSubscriber Only
November 22, 2020 10:26 IST
While most public health experts focused on hand-washing and surface transmission, and other countries debated over wearing masks, as early as March Oshitani concentrated on tracking down clusters of infections and ensuring people avoid the Three C’s.
Regeneron gets emergency US clearance for Covid-19 therapySubscriber Only
November 22, 2020 07:21 IST
The treatment, administered to President Donald Trump after he contracted the coronavirus in October, consists of two monoclonal antibodies that target the spike protein used by the virus to enter cells.
Moderna to charge $25-$37 for COVID-19 vaccine, says CEO
November 22, 2020 13:44 IST
Moderna has said its experimental vaccine is 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial
COVID-19 infection offers protection from reinfection for at least 6 months: Study
November 21, 2020 19:55 IST
Prof Eyre explained that we know from a previous study that antibody levels fall over time, but this latest study shows that there is some immunity in those who have been infected.
Chinese Covid-19 vaccine enters third-stage human trial
November 20, 2020 21:26 IST
This is China's first phase-3 efficacy study for a Recombinant subunit COVID-19 vaccine candidate, Anhui Zhifei Longcom Biopharmaceutical, said in a statement on Thursday.
Oxford-AstraZeneca Covid-19 vaccine candidate shows promise among elderly in trials
November 19, 2020 14:06 IST
The Oxford-AstraZeneca Covid-19 vaccine candidate had been among the front-runners in global efforts to develop shots to protect against infection with the novel coronavirus, or SARS-CoV-2.
New York City to close public schools again as virus cases riseSubscriber Only
November 19, 2020 09:45 IST
New York City’s entire public school system will shutter on Nov. 19, the schools chancellor Richard A. Carranza wrote in an email to principals, in a worrisome signal that a second wave of the coronavirus has arrived.
Sero survey: ‘38% of Kashmir people developed Covid antibodies’Subscriber Only
November 19, 2020 01:14 IST
The survey, in which 6,000 samples from all 10 districts of Kashmir were tested, showed that 38.8 per cent of the population has developed the antibodies.
Pfizer ends Covid-19 vaccine trial with 95% efficacy, to seek emergency-use authorisation
November 18, 2020 21:44 IST
The only severe adverse event that affected more than 2% of those vaccinated was fatigue, which affected 3.7% of recipients after the second dose.
China’s COVID-19 vaccine induces quick immune response within four weeks: Study
November 18, 2020 08:36 IST
While the early to mid-stage trials were not designed to assess the efficacy of CoronaVac, researchers said it could provide sufficient protection, based on their experience with other vaccines and data from preclinical studies with macaques.
What does Covid-19 vaccine effectiveness mean?
November 17, 2020 14:41 IST
Coronavirus vaccine: The broad, early effectiveness figures don't tell the whole story. Scientists also need to understand how well the vaccine protects people in different age groups and demographic categories.
South Korea to tighten social distancing, warns of new COVID-19 crisis
November 17, 2020 09:06 IST
Starting Tuesday midnight, tighter curbs will ban public gatherings of 100 people or more, limit religious services and audiences at sporting events to 30% capacity, and require high-risk facilities including clubs and karaoke bars to broaden distance among guests.
Moderna says Covid vaccine 95% effective; may be promising option in IndiaSubscriber Only
November 17, 2020 13:10 IST
Last week, Pfizer-BioNTech and the Russian makers of the Sputnik V vaccine announced that their candidates had been found to be over 90 per cent effective in preliminary results of phase 3 human trials.
Johnson & Johnson unit to start phase 3 covid vaccine trial in UKSubscriber Only
November 16, 2020 14:42 IST
The vaccine is the third candidate to be tested in the U.K., alongside one from an AstraZeneca in partnership with the University of Oxford and another from Novavax Inc., it said.
Johnson & Johnson’s covid vaccine gets another $1 billion funding boostSubscriber Only
November 15, 2020 07:26 IST
The Biomedical Advanced Research and Development Authority will commit about $454 million in additional money to the Phase 3 Ensemble trial, which seeks to evaluate the efficacy of the company’s vaccine candidate as a single-dose.
Germany plans hundreds of vaccine centers in December: ReportSubscriber Only
November 15, 2020 07:22 IST
Health Minister Jens Spahn has signaled that his country is looking to secure 100 million doses of the vaccine being developed by German company BioNTech and its big pharma partner Pfizer Inc., saying it’s likely to be ready in the first quarter of next year.
Elon Musk says he ‘most likely’ has moderate case of covidSubscriber Only
November 15, 2020 09:36 IST
Musk first disclosed on Twitter Friday that he had received inconclusive results from coronavirus tests using Becton, Dickinson and Co.’s rapid antigen test, getting two negative and two positive results.
India to get 100 million Astrazeneca vaccine shots by December: Adar PoonawallaSubscriber Only
November 14, 2020 13:10 IST
If final-stage trial data show AstraZeneca’s candidate gives effective protection from Covid-19, the Serum Institute of India may get emergency authorization from New Delhi by December, said Adar Poonawalla.
Australian COVID-19 vaccine candidate produces antibody response in early tests
November 13, 2020 14:14 IST
Pharmaceutical companies are racing to develop effective treatments for the disease amid a surge in COVID-19 cases that has killed over a million people and battered the world's economy.
China under pressure to reveal Covid-19 vaccine data after Pfizer successSubscriber Only
November 13, 2020 10:08 IST
Now as Beijing develops a vaccine, the need for transparency is proving essential to win back trust. American drugmaker Pfizer Inc. and German biotechnology firm BioNTech SE announced this week that its vaccine appears more than 90% effective in stopping Covid-19 infections.
Potential COVID vaccine, being developed by Queensland Univ, could be available in third quarter of 2021: Minister
November 13, 2020 10:20 IST
Biotech firm CSL has completed the manufacturing of the vaccine candidate to allow the third stage of clinical trials to begin.
Brazil trial of China’s Sinovac vaccine not affected by suspension
November 13, 2020 10:21 IST
The trial was paused late Monday after the death of a participant, which was registered in Sao Paulo as a suicide.
Advertisement
BEST OF EXPRESS
EntertainmentRajesh Khanna stood in line for a public toilet with a dabba; it gave him his last hit; Dimple Kapadia called his state 'pathetic'
TrendingPharmaceutical company’s finance head quits due to Delhi air pollution: ‘Kindly relieve me asap’
Advertisement
Must Read
Advertisement
